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Solanum nigrum or locally just black nightshade is a species in the Solanum genus, native to Eurasia and 
introduced in the Americas, Australasia, and South Africa. While this plant has lots of properties, the aim of this 
study is to overview its therapeutic effects of Solanum nigrum. This review article was carried out by searching 
studies in PubMed, Medline, Web of Science, and IranMedex databases from 1998 to 2016.totally, of 93 found 
articles, 60 articles were included. The search terms were “Solanum nigrum”, “therapeutic”, “pharmacological”,  
Various studies have shown that Solanum nigrum Possess Anti-Tumor effect, Anti-Cancer Activity, Hepatoprotective 
Effect, Anti-fungal effect, Anti -larvicidal effect, Anti-Stress effect,  Antioxidative effect, Antiallergic effect, 
Estrogenic activity. Although Solanum nigrum have a long history of medicinal use within the traditional Chinese 
system, it has been only recently in the West that we have begun to understand their pharmacological possibilities. 
Solanum nigrum has a wide range of potential therapeutic applications in anti-cancer and anti-tumor activities. 
 





It is proved that herbal medicine is effective in the treatment of many diseases[1-20].European black nightshade 
(Solanum nigrum) or locally just black nightshade) is a species in the Solanum genus, native to Eurasia and 
introduced in the Americas, Australasia, and South Africa. Parts of this plant can be toxic to livestock and humans. 
Nonetheless, ripe berries and cooked leaves of edible strains are used as food in some locales, and plant parts are 
used as a traditional medicine. A tendency exists in literature to incorrectly refer to many of the other "black 
nightshade" species as "Solanum nigrum"[21]. 
 
Solanum nigrum has been recorded from deposits of the Paleolithic and Mesolithic era of ancient Britain and it is 
suggested by the botanist and ecologist Edward Salisbury that it was part of the native flora there before 
Neolithicagriculture emerged. The species was mentioned by Pliny the Elder in the first century AD and by the great 
herbalists, including Dioscorides. In 1753, Carl Linnaeus described six varieties of Solanum nigrum in Species 
Plantarum[22].  
 
Black nightshade is a common herb or short-lived perennial shrub, found in many wooded areas, as well as 
disturbed habitats. It reaches a height of 30 to 120 cm (12 to 47 in), leaves 4.0 to 7.5 cm (1.6 to 3.0 in) long and 2 to 
5 cm (1 to 2 in) wide; ovate to heart-shaped, with wavy or large-toothed edges; both surfaces hairy or hairless; 
petiole 1 to 3 cm (0.5 to 1 in) long with a winged upper portion. The flowers have petals greenish to whitish, 
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recurved when aged and surround prominent bright yellow anthers. The berry is mostly 6 to 8 mm (0.24 to 0.31 in) 
in diam., dull black or purple-black. In India, another strain is found with berries that turn red when ripe[23].  
 
Sometimes Solanum nigrum is confused for the more toxic deadly nightshade, Atropa belladonna, in a different 
Solanaceae genus altogether. A comparison of the fruit shows that the black nightshade berries grow in bunches, the 
deadly nightshade berries grow individually. 
 
The plant has a long history of medicinal usage, dating back to ancient Greece. "... In the fourteenth century, we hear 
of the plant under the name of Petty Morel being used for canker and with Horehound and wine taken for dropsy." It 
was a traditional European medicine used as a strong sudorific, analgesic and sedative with powerful narcotic 
properties, but was considered a "somewhat dangerous remedy". Internal use has fallen out of favor in 
Westernherbalism due to its variable chemistry and toxicity, but it is used topically as a treatment for herpes 
zoster[24].  
 
Solanum nigrum is an important ingredient in traditional Indian medicines. Infusions are used in dysentery, stomach 
complaints, and fever. The juice of the plant is used on ulcers and other skin diseases. The fruits are used as a tonic, 
laxative, appetite stimulant, and for treating asthma and "excessive thirst". Traditionally the plant was used to treat 
tuberculosis. It is known as peddakashapandlakoora in the Telangana region. This plant's leaves are used to treat 
mouth ulcers that happen during winter periods of Tamil Nadu, India. It is known as manathakkalikeerai in Tamil 
Nadu and kaagesoppu in Karnataka, and apart from its use as a home remedy for mouth ulcers, is used in cooking 
like spinach. In North India, the boiled extracts of leaves and berries are also used to alleviate liver-related ailments, 
including jaundice. In Assam, the juice from its roots is used against asthma and whooping cough[24-27].  
 
Solanum nigrum is a widely used plant in oriental medicine where it is considered to be antitumorigenic, 
antioxidant, anti-inflammatory, hepatoprotective, diuretic, and antipyretic[28].  
 
Anti-Tumor effect 
A polysaccharide fraction from Solanum nigrum, SN-ppF3 was examined regarding to immunomodulatory activity 
.These results suggested that tumor suppression mechanisms observed in SN-ppF3-treated mice were most probably 
due through enhancing the host immune response [29]. 
 
Effects of crude polysaccharides isolated from Solanum nigrum L. on erythrocyte membranes of tumor-bearing 
S180 and H22 in mice was investigated. Solanum nigrum L.-type mice transplanted tumor can affect the red blood 
cell membrane fluidity and re-closed, through the red cell membrane of red blood cells to enhance the immune 
function of the possibility of erythrocyte immunity against tumor formation garland provide experimental basis [30]. 
The anti-tumour effect of polysaccharides from Solanum nigrum Linne, and its relationship with the immune 
function of tumour-bearing organisms was investigated. Different doses of polysaccharides from Solanum nigrum 
Linne significantly inhibited the growth of mouse H22 solid tumours, improved the survival time of tumour-bearing 
mice, increased the proliferation of lymphocytes, elevated the levels of IL-2, and increased the concentration of 
calcium ions in the lymphocytes. Polysaccharides from Solanum nigrum Linne have certain anti-tumour effect, 
which is related with the cellular immune function that regulates the body[31]. 
 
The effects of Solanum nigrum fractions in mouse peritoneal macrophages were determined. The results indicate 
that the anti-inflammatory compounds of Solanum nigrum exist preferentially in the nonpolar fraction, ruling out the 
possibility that diosgenin and α-solanine are the likely candidates. The inhibition of iNOS, TNF-α and IL-6 by the 
chloroform fraction may be partly due to the suppression of p38, JNK and ERK1/2. Further study is required to 
identify the active compounds of Solanum nigrum[32]. 
 
The effects of the crude polysaccharides isolated from Solanum nigrum Linne (SNL-P) in vitro and in vivo against 
U14 cervical cancerwas examined. The data showed that SNL-P possess potent antitumor activity and SNL-P might 
exert antitumor activity via activation of different immune responses in the host rather than by directly attacking 
cancer cells on the U14 cervical cancer bearing mice. Thus, SNL-P could be used as an immunomodulatory and an 
anticancer agent [33]. 
 
Sepide Miraj Der Pharma Chemica, 2016,8 (17):62-68 
_____________________________________________________________________________ 
64 
The anti-tumor active compound of polysaccharides isolated from Solanum nigrum Linne (SNL-P) and the thymus 
protective effects of this active compound were evaluated.SNL-P1a had significant growth inhibition effect on U14 
cervical cancer and protective effect on thymus tissue of tumor-bearing mice [34]. 
 
Anti-Cancer Activity 
The suppression of EMT in MCF-7 breast cancer cells treated with AESN was evaluated. The results suggested that 
AESN could inhibit EMT of MCF-7 breast cancer cells mediated by attenuation of mitochondrial function. AESN 
could be potentially beneficial in treating breast cancer cells, and may be of interest for future studies in developing 
integrative cancer therapy against proliferation, metastasis, and migration of breast cancer cells[35].  
 
the antitumor effects of AE-SN was evaluated and the synergistic effects of AE-SN with docetaxel On the human 
endometrial cancer cell lines was assessed and result showed that AE-SN treatment was effective in suppressing 
endometrial cancer cells via the autophagic pathway and was also capable of enhancing the cytotoxicity of docetaxel 
in human endometrial cancer cells. Our results provide meaningful evidence for integrative cancer therapy in the 
future[36]. 
 
the inhibitory effect of solamargine (SM), a major steroidal alkaloid glycoside purified from SNL, on human 
hepatoma SMMC-7721 cells and investigate the possible mechanism of SM was evaluated. Result indicated that SM 
exerted potential anticancer activity on SMMC-7721 cells in vitro through the activation of caspase-3 and the 
regulation of the cell cycle progression to induce apoptosis and inhibit hepatoma cells proliferation[37]. 
 
the growth-inhibitory effects of the SN extract was evaluated. a polyphenolic extract of Solanum nigrum 
(SN)demonstrated differentially causes cell cycle arrest and apoptosis in various human prostate cancer cells without 
affecting normal prostate epithelial cells. Results showed that the SN extract is capable of selectively inhibiting 
cellular proliferation and accelerating apoptotic events in prostate cancer cells. SN may be developed as a promising 
therapeutic and/or preventive agent against prostate cancer[38]. 
 
the tumor-suppression efficiency of AE-SN integrated with a standard chemotherapeutic drugwas examined. The 
results suggested that the integrated treatment with AE-SN-potentiated cisplatin and doxorubicin induced 
cytotoxicity through the cleavage of caspase-7 and accumulation of microtubule-associated protein-1 light .AE-SN 
can potentially be used in novel integrated chemotherapy with cisplatin or doxorubicin to treat HCC patients [39].  
 
Tumor suppression efficacy was determined using the ES-2, SKOV-3, and OVCAR-3 human ovarian cancer cell 
lines. Result suggested that the AE-SN exhibited tumor suppression efficacy and improved the tumor suppression 
efficiency of cisplatin, doxorubicin, and docetaxel in human ovarian cancer cells. Therefore, the AE-SN is a 
candidate antitumor ingredient that can be used in developing future integrated chemotherapy for managing ovarian 
cancer[40].  
 
Cytotoxicity of specific concentrations of hydro-alcoholic extracts of C. pepo and Solanum nigrum was studied on 
normal rat fibroblast and cancer (HepG2 and CT26) cell lines. It is concluded that the extract of Solanum nigrum has 
almost similar cytotoxicity to the extract of T. baccata on cancer cells [41]. 
 
It was demonstrated that 12-o-tetradecanoylphobor-13-acetate (TPA) and constitutively activated PKC alpha 
significantly increased migration and invasion of HepG2 cells, while treatment with water or polyphenol extracts of 
SN attenuated TPA-induced migration and invasion. Results revealed the antimigration and anti-invasion effects of 
both extracts derived from SN, which may act as a promising therapeutic agent for the treatment of hepatocellular 
carcinoma [42]. 
 
the inhibitive effect of Solanum nigrum Linn. water extract (SNWE) on melanoma metastasis and dissect the 
underlying mechanisms of SNWE actions was evaluated. The results indicated SNWE significantly inhibited B16-
F1 cell migration and invasion. Meanwhile, decreased Akt activity and PKCα, Ras, and NF-κB protein expressions 
were detected in dose-dependent manners. In line with this notion, >50% reduced tumor weight and lung metastatic 
nodules were observed in 1% SNWE fed mice. This was associated with reduced serum MMP-9 as well as Akt 
activity and PKCα, Ras, and NF-κB protein expressions [43]. 
Sepide Miraj Der Pharma Chemica, 2016,8 (17):62-68 
_____________________________________________________________________________ 
65 
Inhibitive effect on hepatocarcinoma cell growth of a polyphenolic extract of Solanum nigrum L. was evaluated. 
This study shows that SNPE is a potent agent for HCC treatment through targeting G(2)/M arrest and apoptosis 
induction, achieving cell growth inhibition[44]. 
 
The bioactive properties of lunasin from Solanum nigrum L. (SNL) was reported. Result illustrated that Lunasin 
isolated from autoclaved SNL inhibited core histone H3 and H4 acetylation, the activities of the HATs, and the 
phosphorylation of the Rb protein. Lunasin in the crude protein and in the autoclaved crude protein was very stable 
to pepsin and pancreatin in vitro digestion, while the synthetic pure lunasin was digested at 2 min after the reaction. 
We conclude that lunasin is a bioactive and bioavailable component in SNL and that consumption of SNL may play 
an important role in cancer prevention [45]. 
 
Strong cytotoxic effect of the extract of SN (SNE) was demonstrated a toward HepG2 cells. The findings indicate 
that SNE induced cell death in hepatoma cells via two distinct antineoplastic activities of SNE, the ability to induce 
apoptosis and autophagocytosis, therefore suggesting that it may provide leverage to treat liver cancer[46].  
 
the tumor suppression efficacy of AE-SN using DLD-1 and HT-29 human colorectal carcinoma cells was evaluated 
and The results indicated that AE-SN induced autophagy via microtubule-associated protein 1 light chain 3 A/B II 
accumulation but not caspase-3-dependent apoptosis in both cell lines. AE-SN also demonstrated a combined drug 
effect with all tested drugs by enhancing cytotoxicity in tumor cells. Our results suggest that AE-SN has potential in 
the development of complementary chemotherapy for colorectal cancer[47].  
 
Organic solvent and aqueous extracts obtained from berries of Solanum nigrum for antiproliferative activity on 
leukemic cell lines was evaluated. Results indicated increased cytotoxicity with increasing extract concentrations. 
Comparative analysis indicated that 50% inhibitory concentration value of methanol extract is the lowest on both 
cell lines[48]. 
 
The effect of Solanum nigrum on adhesion, migration and invasion in human colon carcinoma RKO cells was 
evaluated. Solanum nigrum may inhibit the proliferation, adhesion, migration and invasive abilities in RKO cells. 
The present study provides new insight into the application of Solanum nigrum for colon carcinoma treatment that 
are worthy of further study[49]. 
 
Hepatoprotective Effect 
the protective effects of Solanum nigrum against alcoholic liver damage in primary hepatocytes and mice, using 
glutathione S-transferase alpha 1 (GSTA1) as an indicator was investigated. The results suggested that Solanum 
nigrum has hepatoprotective effects against ethanol-induced injury both in vitro and in vivo, and can protect the 
integrity of hepatocytes and thus reduce the release of liver GSTA1, which contributes to improved liver 
detoxification [50]. 
 
The ethnopharmacological use of a traditional formulation in hepatoprotection against paracetamol-induced 
hepatotoxicity was examined and the result showed that The polyherbal extract exhibits a significant 
hepatoprotective effect in vivo. The study contributes to its use in traditional Ayurveda system for the management 
of liver diseases. 
 
The ethnopharmacological use of a traditional formulation in hepatoprotection against paracetamol induced 
hepatotoxicity was evaluated and The finding demonstrated its usefulness in traditional Ayurveda system for the 
management of liver diseases [51]. 
 
The inhibitory effect of aqueous extracts from Solanum nigrum (AESN) on AGEs-induced RAGE signaling and 
activation of hepatic stellate cells (HSCs) and hyperglycemia induced by high-fat diet with ethanol was investigated. 
The results suggest that AESN may be further explored as a novel anti-fibrotic strategy for the prevention of liver 
disease[52]. 
 
The hepatoprotective effect of Solanum nigrum Linn (SN) dried fruits and their ethanolic extract against CdCl2 
toxicity was determined. The treatment with dried fruits and their ethanolic extract in CdCl2-intoxicated rats (groups 
5 and 6) ameliorated and improved these harmful effects in all above parameters either for blood or liver. The results 
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of this study suggest the protective effect of Solanum nigrum against liver injury happened by CdCl2 which may be 
attributed to its hepatoprotective activity and thereby[53].  
Anti-fungal effect 
Anti-fungal effect of Solanum nigrum L. was investigated and result showed that the production of solamargine  by 
a cultivable fungal endophyte at a significant yield is a new observation. Further experiments such as media 
optimization, OSMAC (One Strain Many Compounds) or epigenetic modifiers could be applied to enhance the 
fungal solamargine production[54]. 
 
Anti-larvicidal effect 
The biocontrol potentiality of active ingredient isolated from ethyl acetate extract of mature leaves of Solanum 
nigrum L. (Solanaceae) was investigated. The findings indicated that there is a clear dose-dependent mortality, as 
the rate of mortality (Y) was positively correlated with the concentrations of the compound (X); having regression 
coefficient value close to 1[55]. 
 
Anti-Stress effect 
The prophylactic or curative antioxidant efficacy of crude extract and the active constituent of Solanum nigrum 
leaves were evaluated .result suggested that Brain is vulnerable to stress induced prooxidant insult due to high levels 
of fat content. Thus, as a safe herbal medication the Solanum nigrum leaves extract or its isolated constituents can be 
used as nutritional supplement for scavenging free radicals generated in the brain due to physical or psychological 
stress or any neuronal diseases per se[56].  
 
 Antioxidative effect 
Effects of endophytic bacterium inoculation on plant growth was evaluated. The beneficial effect was more obvious 
at relatively low Cd concentration (10 µM). Based on the alteration of nutrient uptake and activated oxygen 
metabolism in infected plants, the possible mechanisms of endophytic bacterium in Cd phytotoxicity reduction can 
be concluded as uptake enhancement of essential mineral nutrition and improvement in the antioxidative enzymes 
activities in infected plant(57). 
 
The protective effect of lunasin purified from Solanum nigrum L. against oxidative DNA was investigated. Result 
showed that lunasin protects DNA from oxidation by blocking fenton reaction between Fe(2+) and H(2)O(2) by 




Potential of the plant berries in the treatment of asthma was evaluated. The petroleum ether extract of Solanum 
nigrum berries can inhibits parameters linked to the asthma disease [59]. 
 
Estrogenic activity 
The estrogenic potential of Solanum nigrum fruits by in vitro and in vivo assays was evaluated. Result demonstrate 
the hormone like activity of Solanum glycosides both in vitro and in vivo in mouse, which needs to be further 




Although Solanum nigrum have a long history of medicinal use within the traditional Chinese system, it has been 
only recently in the West that we have begun to understand their pharmacological possibilities. Solanum nigrum has 
a wide range of potential therapeutic applications in anti-cancer and anti-tumor activities. 
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